Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systematic administration
- 22 April 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 214 (2-3) , 285-287
- https://doi.org/10.1016/0014-2999(92)90132-n
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholdsNeurochemical Research, 1992
- The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholdsBrain Research, 1991
- The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodentsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐d‐aspartate receptor antagonists with oral activityBritish Journal of Pharmacology, 1990
- Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdalaBrain Research, 1989
- Role of the receptors in the development and maintenance of hippocampal kindling in ratsNeuroscience Letters, 1988
- Determination of the pharmacokinetics of 2-amino-7-phosphonoheptanoate in rat plasma and cerebrospinal fluidNeuroscience Letters, 1988
- Is amygdala kindling in rats a model for drug-resistant partial epilepsy?Experimental Neurology, 1986
- Kindling: An animal model of complex partial epilepsyAnnals of Neurology, 1984
- Uptake of a novel anticonvulsant compound, 2-amino-7-phosphono-[4,5-3H]Heptanoic acid, into mouse brainNeuroscience Letters, 1983